Events /// Investor News /// Investment Case /// Resources
Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders.
Upcoming Events and Highlights
Investor News
Share Price / Index
November 12, 2024
Third quarter of 2024
Bayer: Strategic progress in challenging business environment – Group outlook confirmed in nearly all parameters
October 19, 2024
Not intended for U.S. and UK Media
Long-term efficacy and safety profile of Eylea™ 8 mg with extended dosing intervals in diabetic macular edema confirmed at three years
October 15, 2024
Not intended for U.S. and UK Media
Bayer submits EU marketing authorization application for elinzanetant to treat moderate to severe vasomotor symptoms
Discover More
